Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 662

1.

Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature.

La Salvia A, Brizzi MP, Trevisi E, Parisi F, Muratori L, Atzeni F, Di Maio M, Scagliotti GV.

Acta Oncol. 2019 Oct 4:1-5. doi: 10.1080/0284186X.2019.1672891. [Epub ahead of print] No abstract available.

PMID:
31583924
2.

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172).

Schadendorf D, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R, Grigoryeva E, Young TC, Nathan P.

Eur J Cancer. 2019 Sep 30;121:144-153. doi: 10.1016/j.ejca.2019.08.014. [Epub ahead of print]

PMID:
31581055
3.

Prophylactic cranial irradiation in extensive disease small cell lung cancer: An endless debate.

Picardi C, Caparroti F, Di Maio M, Kaššák F, Banna GL, Addeo A.

Crit Rev Oncol Hematol. 2019 Sep 12;143:95-101. doi: 10.1016/j.critrevonc.2019.08.010. [Epub ahead of print] Review.

PMID:
31563079
4.

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, Cowey CL, Schadendorf D, Wagstaff J, Dummer R, Ferrucci PF, Smylie M, Hogg D, Hill A, Márquez-Rodas I, Haanen J, Guidoboni M, Maio M, Schöffski P, Carlino MS, Lebbé C, McArthur G, Ascierto PA, Daniels GA, Long GV, Bastholt L, Rizzo JI, Balogh A, Moshyk A, Hodi FS, Wolchok JD.

N Engl J Med. 2019 Sep 28. doi: 10.1056/NEJMoa1910836. [Epub ahead of print]

PMID:
31562797
5.

Characteristics of prescription in 29 Level 3 Neonatal Wards over a 2-year period (2017-2018). An inventory for future research.

Gouyon B, Martin-Mons S, Iacobelli S, Razafimahefa H, Kermorvant-Duchemin E, Brat R, Caeymaex L, Couringa Y, Alexandre C, Lafon C, Ramful D, Bonsante F, Binson G, Flamein F, Moussy-Durandy A, Di Maio M, Mazeiras G, Girard O, Desbruyeres C, Mourdie J, Escourrou G, Flechelles O, Abasse S, Rosenthal JM, Pages AS, Dorsi M, Karaoui L, ElGellab A, Le Bail Dantec F, Yangui MA, Norbert K, Kugbe Y, Lorrain S, Pignolet A, Garnier EM, Lapillonne A, Mitanchez D, Jacqz-Aigrain E, Gouyon JB.

PLoS One. 2019 Sep 19;14(9):e0222667. doi: 10.1371/journal.pone.0222667. eCollection 2019.

6.

Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial.

Di Giacomo AM, Covre A, Finotello F, Rieder D, Danielli R, Sigalotti L, Giannarelli D, Petiprez F, Lacroix L, Valente M, Cutaia O, Fazio C, Amato G, Lazzeri A, Monterisi S, Miracco C, Coral S, Anichini A, Bock C, Nemc A, Oganesian A, Lowder JN, Azab M, Fridman WH, Sautes-Fridman C, Trajanoski Z, Maio M.

Clin Cancer Res. 2019 Sep 17. pii: clincanres.1335.2019. doi: 10.1158/1078-0432.CCR-19-1335. [Epub ahead of print]

PMID:
31530631
7.

Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol.

Riva S, Bryce J, De Lorenzo F, Del Campo L, Di Maio M, Efficace F, Frontini L, Giannarelli D, Gitto L, Iannelli E, Jommi C, Montesarchio V, Traclò F, Vaccaro CM, Gallo C, Perrone F.

BMJ Open. 2019 Sep 9;9(9):e031485. doi: 10.1136/bmjopen-2019-031485.

8.

Looking for the right way: right coronary artery originating from a left anterior descending acutely occluded just distally to the bifurcation.

Spadaro P, Di Maio M, Scotto Di Uccio F, Punzo F, Tuccillo A, Tuccillo B.

J Cardiovasc Med (Hagerstown). 2019 Sep 2. doi: 10.2459/JCM.0000000000000823. [Epub ahead of print]

PMID:
31483327
9.

CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer.

Loupakis F, Biason P, Prete AA, Cremolini C, Pietrantonio F, Pella N, Dell'Aquila E, Sperti E, Zichi C, Intini R, Dadduzio V, Schirripa M, Bergamo F, Antoniotti C, Morano F, Cortiula F, De Maglio G, Rimassa L, Smiroldo V, Calvetti L, Aprile G, Salvatore L, Santini D, Munari G, Salmaso R, Guzzardo V, Mescoli C, Lonardi S, Rugge M, Zagonel V, Di Maio M, Fassan M.

Br J Cancer. 2019 Oct;121(7):593-599. doi: 10.1038/s41416-019-0560-0. Epub 2019 Sep 2.

PMID:
31474758
10.

Predicting acute adverse contrast mean reactions following cardiac catheterization: a complex undertaking.

Di Maio M, Capodanno D.

J Thorac Dis. 2019 Jul;11(7):2700-2704. doi: 10.21037/jtd.2019.07.24. No abstract available.

12.

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172).

Nathan P, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R, Grigoryeva E, Young TC, Schadendorf D.

Eur J Cancer. 2019 Sep;119:168-178. doi: 10.1016/j.ejca.2019.07.010. Epub 2019 Aug 21.

PMID:
31445199
13.

Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018.

Marandino L, De Luca E, Zichi C, Lombardi P, Reale ML, Pignataro D, Di Stefano RF, Ghisoni E, Mariniello A, Trevisi E, Leone G, Muratori L, La Salvia A, Sonetto C, Buttigliero C, Tucci M, Aglietta M, Novello S, Scagliotti GV, Perrone F, Di Maio M.

Clin Genitourin Cancer. 2019 Oct;17(5):332-347.e2. doi: 10.1016/j.clgc.2019.07.007. Epub 2019 Jul 20. Review.

PMID:
31416754
14.

Addressing the Challenge of Atrial Fibrillation Management: How to Differentiate the Approach Depending on Left Ventricular Ejection Fraction.

De Vecchis R, Paccone A, Di Maio M.

Cardiol Res. 2019 Aug;10(4):253-254. doi: 10.14740/cr896. Epub 2019 Jul 31. No abstract available.

15.

Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study.

De Vecchis R, Paccone A, Di Maio M.

Cardiol Res. 2019 Aug;10(4):223-229. doi: 10.14740/cr909. Epub 2019 Jul 31.

16.

Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial.

Eggermont AMM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebbe C, Ferraresi V, Smylie M, Weber JS, Maio M, Hosein F, de Pril V, Kicinski M, Suciu S, Testori A.

Eur J Cancer. 2019 Sep;119:1-10. doi: 10.1016/j.ejca.2019.07.001. Epub 2019 Aug 7.

PMID:
31400634
17.

Dopamine affects short-term memory corruption over time in Parkinson's disease.

Fallon SJ, Gowell M, Maio MR, Husain M.

NPJ Parkinsons Dis. 2019 Aug 5;5:16. doi: 10.1038/s41531-019-0088-2. eCollection 2019.

18.

Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.

Russo V, Attena E, Di Maio M, Mazzone C, Carbone A, Parisi V, Rago A, D'Onofrio A, Golino P, Nigro G.

J Thromb Thrombolysis. 2019 Aug 5. doi: 10.1007/s11239-019-01923-9. [Epub ahead of print]

PMID:
31385163
19.

[Description of adverse events in publications of clinical trials: much room for improvement.]

Di Maio M, Antonuzzo A, Bossi P.

Recenti Prog Med. 2019 Jul-Aug;110(7):323-324. doi: 10.1701/3197.31742. Italian.

PMID:
31379365
20.

Bone-targeted therapy in castration-resistant prostate cancer: where do we stand?

Gómez Rivas J, Carrion DM, Alvarez-Maestro M, Cathelineau X, Sanchez-Salas R, Di Lorenzo G, Di Maio M, Paul A, Martinez-Piñeiro L, Sartor O, Saad F, Debruyne F.

Minerva Urol Nefrol. 2019 Jul 25. doi: 10.23736/S0393-2249.19.03420-9. [Epub ahead of print]

PMID:
31353876
21.

A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study.

Loupakis F, Intini R, Cremolini C, Orlandi A, Sartore-Bianchi A, Pietrantonio F, Pella N, Spallanzani A, Dell'Aquila E, Scartozzi M, De Luca E, Rimassa L, Formica V, Leone F, Calvetti L, Aprile G, Antonuzzo L, Urbano F, Prenen H, Negri F, Di Donato S, Buonandi P, Tomasello G, Avallone A, Zustovich F, Moretto R, Antoniotti C, Salvatore L, Calegari MA, Siena S, Morano F, Ongaro E, Cascinu S, Santini D, Ziranu P, Schirripa M, Buggin F, Prete AA, Depetris I, Biason P, Lonardi S, Zagonel V, Fassan M, Di Maio M.

Eur J Cancer. 2019 Sep;118:121-130. doi: 10.1016/j.ejca.2019.06.008. Epub 2019 Jul 19.

PMID:
31330487
22.

Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy.

Bossi P, Botta L, Bironzo P, Sonetto C, Musettini G, Sbrana A, Di Giannantonio V, Locati LD, Di Maio M, Antonuzzo A.

Future Oncol. 2019 Jul;15(21):2543-2553. doi: 10.2217/fon-2018-0772. Epub 2019 Jun 26.

PMID:
31240949
23.

Impact of primary tumor location on patterns of recurrence and survival of patients undergoing resection of liver metastases from colon cancer.

Russolillo N, Sperti E, Langella S, Menonna F, Allieta A, Di Maio M, Ferrero A.

HPB (Oxford). 2019 Jun 21. pii: S1365-182X(19)30564-7. doi: 10.1016/j.hpb.2019.05.014. [Epub ahead of print]

PMID:
31235431
24.

Assessment of groundwater geochemistry and diffusion of hexavalent chromium contamination in an industrial town of Italy.

Tiwari AK, Orioli S, De Maio M.

J Contam Hydrol. 2019 Aug;225:103503. doi: 10.1016/j.jconhyd.2019.103503. Epub 2019 May 16.

PMID:
31153128
25.

Evaluation of groundwater salinization and pollution level on Favignana Island, Italy.

Tiwari AK, Pisciotta A, De Maio M.

Environ Pollut. 2019 Jun;249:969-981. doi: 10.1016/j.envpol.2019.03.016. Epub 2019 Mar 11.

PMID:
31146317
26.

Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors.

Sparaneo A, Fabrizio FP, la Torre A, Graziano P, Di Maio M, Fontana A, Bisceglia M, Rossi A, Pizzolitto S, De Maglio G, Tancredi A, Grimaldi F, Balsamo T, Centra F, Manzorra MC, Trombetta D, Pantalone A, Bonfitto A, Maiello E, Fazio VM, Muscarella LA.

Int J Mol Sci. 2019 May 23;20(10). pii: E2531. doi: 10.3390/ijms20102531.

27.

Assessing Financial Toxicity in Patients With Cancer: Moving Away From a One-Size-Fits-All Approach.

Perrone F, Di Maio M, Efficace F, Gallo C, Giannarelli D, Montesarchio V, Riva S.

J Oncol Pract. 2019 Aug;15(8):460-461. doi: 10.1200/JOP.19.00200. Epub 2019 May 24. No abstract available.

PMID:
31125283
28.

Improving adherence to Ticagrelor in patients after acute coronary syndrome: Results from the PROGRESS trial.

Crisci M, Gragnano F, Di Maio M, Diana V, Moscarella E, Pariggiano I, Di Maio D, Concilio C, Taglialatela V, Fimiani F, Cesaro A, Cirillo PL, Calabrò P.

Curr Vasc Pharmacol. 2019 May 24. doi: 10.2174/1570161117666190524123225. [Epub ahead of print]

PMID:
31124422
29.

State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough.

Bersanelli M, Buti S, De Giorgi U, Di Maio M, Giannarelli D, Pignata S, Banna GL.

Crit Rev Oncol Hematol. 2019 Jul;139:87-90. doi: 10.1016/j.critrevonc.2019.05.003. Epub 2019 May 8. Review.

PMID:
31112887
30.

Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review.

Muratori L, La Salvia A, Sperone P, Di Maio M.

Crit Rev Oncol Hematol. 2019 Jul;139:41-52. doi: 10.1016/j.critrevonc.2019.05.002. Epub 2019 May 3.

PMID:
31112881
31.

The future of mesothelioma treatment: time to shift gear.

Maio M, Calabrò L.

Lancet Respir Med. 2019 Jul;7(7):554-555. doi: 10.1016/S2213-2600(19)30171-7. Epub 2019 May 15. No abstract available.

PMID:
31103413
32.

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma.

Salaroglio IC, Kopecka J, Napoli F, Pradotto M, Maletta F, Costardi L, Gagliasso M, Milosevic V, Ananthanarayanan P, Bironzo P, Tabbò F, Cartia CF, Passone E, Comunanza V, Ardissone F, Ruffini E, Bussolino F, Righi L, Novello S, Di Maio M, Papotti M, Scagliotti GV, Riganti C.

J Thorac Oncol. 2019 Aug;14(8):1458-1471. doi: 10.1016/j.jtho.2019.03.029. Epub 2019 May 9.

33.

The Effects of Conflict on Fertility: Evidence From the Genocide in Rwanda.

Kraehnert K, Brück T, Di Maio M, Nisticò R.

Demography. 2019 Jun;56(3):935-968. doi: 10.1007/s13524-019-00780-8.

PMID:
31062199
34.
35.

How to measure a Hill-Sachs lesion: a systematic review.

Maio M, Sarmento M, Moura N, Cartucho A.

EFORT Open Rev. 2019 Apr 26;4(4):151-157. doi: 10.1302/2058-5241.4.180031. eCollection 2019 Apr. Review.

36.

Second-line treatment options in hepatocellular carcinoma.

Marino D, Zichi C, Audisio M, Sperti E, Di Maio M.

Drugs Context. 2019 Apr 10;8:212577. doi: 10.7573/dic.212577. eCollection 2019. Review.

37.
38.

High Prevalence of Proarrhythmic Events in Patients With History of Atrial Fibrillation Undergoing a Rhythm Control Strategy: A Retrospective Study.

De Vecchis R, Di Maio M, Noutsias M, Rigopoulos AG, Ariano C, Di Biase G.

J Clin Med Res. 2019 May;11(5):345-352. doi: 10.14740/jocmr3805. Epub 2019 Apr 14.

39.

NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy.

Sottile R, Tannazi M, Johansson MH, Cristiani CM, Calabró L, Ventura V, Cutaia O, Chiarucci C, Covre A, Garofalo C, Pontén V, Tallerico R, Frumento P, Micke P, Maio M, Kärre K, Carbone E.

Int J Cancer. 2019 Oct 15;145(8):2238-2248. doi: 10.1002/ijc.32363. Epub 2019 May 13.

PMID:
31018250
40.

Left Atrial Volume during Stress Is Associated with Increased Risk of Arrhythmias in Patients with Hypertrophic Cardiomyopathy.

Limongelli G, Fioretti V, Di Maio M, Verrengia M, Rubino M, Gravino R, Masarone D, D'Andrea A, Ciampi Q, Picano E, Elliott P, Pacileo G.

J Cardiovasc Echogr. 2019 Jan-Mar;29(1):1-6. doi: 10.4103/jcecho.jcecho_45_18.

41.

Successful implementation of infection control measure in a neonatal intensive care unit to combat the spread of pathogenic multidrug resistant Staphylococcus capitis.

Ory J, Cazaban M, Richaud-Morel B, Di Maio M, Dunyach-Remy C, Pantel A, Sotto A, Laurent F, Lavigne JP, Butin M.

Antimicrob Resist Infect Control. 2019 Mar 27;8:57. doi: 10.1186/s13756-019-0512-8. eCollection 2019.

42.

The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life.

Baratelli C, Turco CGC, Lacidogna G, Sperti E, Vignani F, Marino D, Zichi C, De Luca E, Audisio M, Ballaminut D, Bellezza A, Chiotto P, Ciriolo G, Comite R, Codegone F, Florio S, Fusco L, Polimeno L, Pozzi D, Zilio E, Terzolo S, Di Maio M.

Support Care Cancer. 2019 Apr 4. doi: 10.1007/s00520-019-04777-2. [Epub ahead of print]

PMID:
30949832
43.

Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease.

Gragnano F, Fimiani F, Di Maio M, Cesaro A, Limongelli G, Cattano D, Calabrò P.

Intern Emerg Med. 2019 Jun;14(4):621-625. doi: 10.1007/s11739-019-02082-8. Epub 2019 Mar 30. No abstract available.

PMID:
30929131
44.

Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients.

Lambertini M, Di Maio M, Poggio F, Pagani O, Curigliano G, Mastro LD, Paluch-Shimon S, Loibl S, Partridge AH, Azim HA Jr, Peccatori FA, Demeestere I.

Reprod Biomed Online. 2019 May;38(5):835-844. doi: 10.1016/j.rbmo.2018.11.031. Epub 2019 Jan 10.

PMID:
30914152
45.

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment.

Muratori L, Gorzegno G, Sperone P, Andreozzi A, Di Maio M, Scagliotti GV.

Gynecol Oncol Rep. 2019 Feb 16;28:44-46. doi: 10.1016/j.gore.2019.02.004. eCollection 2019 May.

46.

Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-treated Patients with BRAF V600-mutated Metastatic Melanoma.

Yan Y, Wongchenko MJ, Robert C, Larkin J, Ascierto PA, Dréno B, Maio M, Garbe C, Chapman PB, Sosman JA, Shi Z, Koeppen H, Hsu JJ, Chang I, Caro I, Rooney I, McArthur GA, Ribas A.

Clin Cancer Res. 2019 Jun 1;25(11):3239-3246. doi: 10.1158/1078-0432.CCR-18-0720. Epub 2019 Mar 1.

PMID:
30824584
47.

Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era.

Tucci M, Caffo O, Buttigliero C, Cavaliere C, D'aniello C, Di Maio M, Kinspergher S, Maines F, Rizzo M, Rossetti S, Veccia A, Scagliotti GV, Facchini G.

Cancer Treat Rev. 2019 Mar;74:35-42. doi: 10.1016/j.ctrv.2019.01.002. Epub 2019 Jan 7. Review.

PMID:
30738364
48.

Pericardial thrombus and cardiac tamponade after pericardiocentesis with intact heart walls.

Accadia M, Di Maio M, Iengo R, Arnese M, Cocchia R, Scotto Di Uccio F, Tuccillo A, Mercogliano G, Tuccillo B.

Echocardiography. 2019 Apr;36(4):803-805. doi: 10.1111/echo.14276. Epub 2019 Feb 6.

PMID:
30726561
49.

Reply to the letter to the editor 'On the underreporting of health-related quality of life and regulatory approval' by Bhamidipati et al.

Di Maio M, Marandino L, Perrone F.

Ann Oncol. 2019 Apr 1;30(4):658-659. doi: 10.1093/annonc/mdz035. No abstract available.

PMID:
30698648
50.

Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy.

Fazio C, Covre A, Cutaia O, Lofiego MF, Tunici P, Chiarucci C, Cannito S, Giacobini G, Lowder JN, Ferraldeschi R, Taverna P, Di Giacomo AM, Coral S, Maio M.

Front Pharmacol. 2018 Dec 7;9:1443. doi: 10.3389/fphar.2018.01443. eCollection 2018.

Supplemental Content

Support Center